US clears new treatments for MS, atopic dermatitis

29th March 2017 Uncategorised 0

Roche/Genentech’s Ocrevus has been approved by the US Food and Drug Administration to treat both relapsing and primary progressive forms of multiple sclerosis, while Sanofi’s Dupixent was cleared for certain patients with moderate-to-severe atopic dermatitis.

More: US clears new treatments for MS, atopic dermatitis
Source: News